Skip to content

the study of Electro-convulsive therapy on psychiatric patients to understand its effect on clinical symptoms and prognosis

The study of effect of electro-convulsive(MECT) treatment on the clinical profile of mentally ill person in a tertiary care general hospital psychiatry unit (GHPU) - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/060220
Enrollment
120
Registered
2023-11-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders

Interventions

None listed

Sponsors

Maulana azad medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients with catatonia, mania, depression and schizophrenia (diagnosed by ICD-10 criteria) who are planned for MECT (for refusal of food, severely violent or suicidal intention, poor response to medicines and other treatment

Exclusion criteria

Exclusion criteria: 1. Patients with a history of epilepsy either current/remote with/ without medications 2. Pregnancy (to be ruled out with urinary pregnancy test) 3. Those that are on drugs which can modify seizure potential other than psychotropic (e.g. amphetamines, aminophylline, isoniazid, cocaine, tramadol and diphenhydramine) 4. Past history of significant major/ minor head injury as defined in Minor Traumatic Brain Injury (MTBI) Working Group of American Academy of Neurology. 5. Those are not fit for MECT in terms of anaesthesia (e.g. allergic to aesthetic agents) or other medical causes (e.g. recent spine injury, dislocation of joints, brain tumour with increased ICT, recent CVA, MI).

Design outcomes

Primary

MeasureTime frame
To find out the average seizure threshold (ST) to achieve clinically optimal seizure for duration of more than 25 seconds in patients receiving MECTTimepoint: at baseline

Secondary

MeasureTime frame
To study the attitude to MECT among patients and/ or family members & their rate of acceptanceTimepoint: at baseline;To study the effect of MECT in clinical outcome in patients of catatonia, mania, depression & schizophreniaTimepoint: at baseline;To study the rate & reason for discontinuation of MECT in our patients.Timepoint: at baseline;To study the side effect profile of MECTTimepoint: at baseline

Countries

India

Contacts

Public ContactPartha Sarathi Biswas

Maulana azadmedical college

psbiswasmamc@gmail.com9718599095

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026